Effect of glaucoma tube shunt parameters on cornea endothelial cells in patients with Ahmed valve implants

Euna B Koo1, Jing Hou, Ying Han

  • 1*Department of Ophthalmology, University of California San Francisco, San Francisco, CA; †Department of Ophthalmology, People's Hospital, Peking University, Beijing, China; ‡Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA; and §Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD.

Cornea
|November 14, 2014
PubMed

Insights

Ahmed valve surgery can impact corneal endothelial cell density (ECD). Tubes placed closer to the cornea are associated with greater endothelial cell loss, a key finding for glaucoma patients.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Corneal Science

Background:

  • Ahmed valve implantation is a common surgical procedure for glaucoma management.
  • Corneal endothelial cells are crucial for maintaining corneal clarity and function.
  • Understanding factors affecting endothelial cell density post-surgery is vital for patient outcomes.

Purpose of the Study:

  • To evaluate the impact of Ahmed valve tube parameters on corneal endothelial cell density (ECD).
  • To compare endothelial cell loss in the superotemporal (ST) cornea with the inferonasal (IN) cornea after glaucoma surgery.

Main Methods:

  • Anterior segment optical coherence tomography was used to measure tube parameters.
  • Corneal endothelial cell density and pachymetry were assessed in ST and IN locations.
  • Comparison of ECD and corneal thickness between ST and IN corneas in patients with Ahmed valves and control subjects.

Main Results:

  • Eyes with Ahmed valve surgery showed significantly lower ECD in the ST endothelium compared to the IN endothelium.
  • The relative reduction in ST ECD was comparable to that in pseudophakic control eyes.
  • Tube distance to the cornea and tube angle were identified as risk factors for ST endothelial cell loss, with distance being significant in multivariate analysis.

Conclusions:

  • Closer proximity of the Ahmed valve tube to the cornea is associated with increased adjacent endothelial cell loss.
  • This finding highlights the importance of precise tube placement during glaucoma surgery.
  • Further research may refine surgical techniques to minimize endothelial cell damage.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K